BioMedha is a UK-based pre-clinical CRO. We provide bioscience expertise to the global drug discovery industry. We are industry-experienced In vitro biology-focused scientists undertaking key elements of the early stage drug discovery process. Our expertise includes:

• Immunology, Oncology, Immuno-oncology, and inflammation studies
• Target validation, assay development, and compound screening from Hit to Lead and to Candidate Selection
• Whole blood assays and immune cell assays
• Flow cytometry analysis
• Cytokine assays and Immunogenicity assessment
• Cell imaging
• Expression studies (protein levels and mRNA levels)
• Functional Studies (Receptor, pathway signalling, bioassays)
• GPCRs: Assay development and screening
• Protein-Protein Interactions (PPI)
• Mechanism of action studies
• Discovery Toxicology studies

Robust In vitro assays are the foundation of effective drug discovery pipelines, and our custom assay development and screening services provide you with consistent performance. BioMedha facilitates the development of such assays across multiple platforms for your project needs.